Skip to main content

Year: 2021

Werner Enterprises Announces Quarterly Dividend and New Stock Repurchase Authorization

OMAHA, Neb., Nov. 12, 2021 (GLOBE NEWSWIRE) — Werner Enterprises, Inc. (NASDAQ: WERN), a premier transportation and logistics provider, is pleased to announce the following actions approved by its Board of Directors (the “Board”) on November 9, 2021. Quarterly Dividends The Board declared a regular quarterly cash dividend of $0.12 (twelve cents) per common share payable to shareholders of record at the close of business on January 3, 2022. This dividend will be paid on January 18, 2022. Werner Enterprises has paid a quarterly cash dividend to its stockholders every quarter since July 1987. Stock Repurchase Program The Board approved a new stock repurchase program under which Werner is authorized to repurchase up to 6 million shares of its common stock. Upon approval of the new program, the Board withdrew the previous stock repurchase...

Continue reading

STEALTHGAS INC. Announces Record Date for Distribution of Imperial Petroleum Inc. Shares for Spin-Off of Tanker Vessels

ATHENS, Greece, Nov. 12, 2021 (GLOBE NEWSWIRE) — StealthGas Inc. (Nasdaq: GASS) (the “Company”),  a ship-owning company primarily serving the liquefied petroleum gas (LPG) sector of the international shipping industry, today announced that the record date for the spin-off distribution of common shares and 8.75% Series A Cumulative Redeemable Perpetual Preferred Shares (“Series A Preferred Shares”) of Imperial Petroleum Inc., the newly formed subsidiary that will act as the holding company for its four tanker vessels, is November 23, 2021. StealthGas stockholders will receive one Imperial Petroleum common share and one Imperial Petroleum Series A Preferred Share for every eight shares and forty-eight shares, respectively, of StealthGas common stock owned at the close of business on November 23, 2021 (the “Record Date”). The distribution...

Continue reading

Capricor’s CEO Dr. Linda Marbán to Serve as Keynote Speaker at TriLink Annual mRNA Day

– The Global, Virtual Event in Partnership with Genetic Engineering News (GEN) and the CRISPR Journal, Taking Place on November 16, 2021 – SAN DIEGO, Nov. 12, 2021 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR) (“Capricor” or “the Company”), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases, today announced that Dr. Linda Marbán, CEO of Capricor, has accepted an invitation to serve as the keynote speaker at the TriLink Biotechnologies Annual mRNA Day Conference, taking place virtually on November 16, 2021. The global event, in partnership with Genetic Engineering News (GEN) and The CRISPR Journal, will provide a broad platform to discuss mRNA-based vaccines and therapeutics across various disease areas....

Continue reading

WW to Host Virtual Investor Event Showcasing New PersonalPoints™ Program

Most personalized offering in company history, proven to deliver clinically significant weight loss Virtual investor event to be hosted on Thursday, November 18, 2021, at 11:00 AM ETNEW YORK, Nov. 12, 2021 (GLOBE NEWSWIRE) — WW International, Inc. (NASDAQ: WW) announced it will host a virtual investor event to highlight the new PersonalPoints™ Program. The event is scheduled for Thursday, November 18, 2021, at 11:00 AM ET. The approximately 30-minute presentation will introduce investors to the most advanced program in WW’s history, sharing a behind-the-scenes look into the development process, science and consumer insights that informed PersonalPoints™, as well as provide an overview of the digital experience, launch process, and plans for the upcoming winter marketing campaign. The event will be followed by a live Q&A...

Continue reading

Rapid Therapeutic Science Laboratories to Present at the Q4 Investor Summit Conference

DALLAS, Nov. 12, 2021 (GLOBE NEWSWIRE) — Rapid Therapeutics Science Laboratories (OTC: RTSL) (“Rapid Therapeutic” or the “Company”), a growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announces today that Chief Executive Officer Donal Schmidt will present a corporate overview at the Q4 Investor Summit Conference, which is being held virtually on November 16 – 17, 2021. Mr. Schmidt will deliver his corporate presentation on Wednesday, November 17 at 2:00 PM ET. Mr. Schmidt will be available for one-on-one meetings throughout the conference. Register HERE to watch the presentation. About Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL)RTSL is a biopharmaceutical company that has developed a new method of formulating and manufacturing...

Continue reading

The New Ireland Fund Announces Renewal of Share Repurchase Program

BOSTON, Nov. 12, 2021 (GLOBE NEWSWIRE) — The New Ireland Fund, Inc. (the “Fund”) (NYSE: IRL) today announced that its Board of Directors has authorized the renewal of the Fund’s share repurchase program. Pursuant to the Board’s renewal of the share repurchase program, the Fund may repurchase up to 5% of its outstanding shares of common stock as of November 1, 2021, in the open market, until the Fund’s fiscal year ending October 31, 2022. The share repurchase program seeks to enhance shareholder value, as repurchases made at a discount will have the effect of increasing the net asset value per share of the Fund’s remaining shares. The amount and timing of the repurchases will be at the discretion of the Fund’s management, subject to market conditions and other factors. There is no assurance that the Fund will purchase shares at...

Continue reading

Capgemini Press Release// Capgemini becomes Nobel International Partner to support innovation and science for a more sustainable future

Press contact:Victoire GruxTel.:+33 6 04 52 16 55E-mail: victoire.grux@capgemini.com Stockholm (Sweden) and Paris (France), November 12, 2021 – In support of its long-term commitment to innovation and technology, Capgemini announces today a three-year global partnership with Nobel Prize Outreach to support innovation and science, in line with Alfred Nobel’s vision and legacy to honor achievements “for the greatest benefit to humankind”Laura Sprechmann, CEO of Nobel Prize Outreach, Aiman Ezzat, CEO of Capgemini and Vidar Helgesen, Executive Director, Nobel Foundation during the signing of the partnership on November 12, 2021 in Stockholm. © Dan Lepp Nobel Prize Outreach Capgemini joins the select group of Nobel International Partners, five companies that are all fueled by the same commitment and passion to share knowledge and excellence...

Continue reading

Information about shares issued by INVL Technology and votes granted

Considering that during the shares buy-back process of INVL Technology (hereinafter – “the Company”), the Company acquired 107,686 shares (0.88 % of own shares) for EUR 295,059.64 from the Company’s shareholders for which they were paid on 12 November 2021, the Company announces the data on shares issued by the Company as of 12 November 2021:Type of shares Number of shares and total voting rights granted by the issued shares, units Number of votes for the quorum of the General Shareholders Meeting, units* Nominal value, EUR Total nominal Value and authorised capital, EUR Portion of the authorised capital, %Ordinary registered shares 12,175,321 12,067,635 0.29 3,530,843.09 100*According to the Law on Securities of the Republic of Lithuania, the shares owned by the Company are not considered to be deducted from the total number...

Continue reading

BriaCell Announces Update on Previously Announced Securities Buyback Program and Participation at Upcoming Conferences

BERKELEY, Calif. and VANCOUVER, British Columbia, Nov. 12, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer and other cancers, today announces the following updates: Pursuant to the securities buyback program announced Sept. 9, 2021, BriaCell has repurchased 202,425 common shares (the “Common Shares”) and 70,246 publicly traded BCTXW warrants (the “Listed Warrants”). As announced, BriaCell may purchase through the facilities of the TSX Venture Exchange (“TSXV”) or the Nasdaq Capital Market (“Nasdaq”) or alternative exchanges (i) up to 1,341,515 Common Shares and (ii) up to 411,962 publicly traded BCTXW Listed Warrants in total, representing...

Continue reading

Novan to Participate in the Virtual Investor Roundtable Event

– Live moderated video webcast discussion among management and Pediatric Dermatology Thought Leader on Wednesday, November 17th at 1:00 PM ET – DURHAM, N.C., Nov. 12, 2021 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan, joined by a pediatric dermatology thought leader, will participate in the Virtual Investor Roundtable Event on Wednesday, November 17, 2021 at 1:00 PM ET. As part of the virtual event, the Company will provide a brief presentation, followed by a moderated roundtable discussion and an interactive Q&A session where all investors and interested parties will have the opportunity to submit questions live during the event. Interested parties may also pre-submit questions in advance of the live event,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.